Kurman R J, Scully R E
Cancer. 1976 Feb;37(2):872-82. doi: 10.1002/1097-0142(197602)37:2<872::aid-cncr2820370236>3.0.co;2-l.
Twenty-one cases of clear cell carcinoma of the endometrium are analysed in an effort to characterize the histologic features and biologic behavior of this type of neoplasm in the uterus and thereby to shed further light on the histogenesis of clear cell carcinoma in the female genital tract. The clinical profile of the patients closely paralleled that of women with the usual types of carcinoma of the endometrium. Fifteen (71%) were stage I, five were stage II, and one was stage IV at diagnosis. An assessment of the clinical stage and depth of myometrial invasion are useful in predicting the prognosis. The actuarial survival for all stages is 55.3% at 5 years, which is somewhat lower than that of adenocarcinoma of the endometrium in general. Operation alone or combined with radiation therapy is the treatment of choice for stage 1 clear cell carcinoma of the endometrium. The most cogent evidence for a müllerian rather than a mesonephric origin for clear cell carcinoma in the female genital tract is its presence in the endometrium, a Müllerian derivative. More specific points that support this concept are the findings of clear cell carcinoma confined to an otherwise benign endometrial polyp in two instances, the initimate admixture of clear cell and typical adenocarcinoma in three other instances, and the absence of mesonephric remnants in any of the 21 cases.
对21例子宫内膜透明细胞癌进行分析,旨在明确该类型子宫肿瘤的组织学特征和生物学行为,从而进一步阐明女性生殖道透明细胞癌的组织发生。患者的临床特征与子宫内膜常见类型癌的女性患者相似。诊断时,15例(71%)为Ⅰ期,5例为Ⅱ期,1例为Ⅳ期。评估临床分期和肌层浸润深度有助于预测预后。所有分期患者的5年精算生存率为55.3%,略低于总体子宫内膜腺癌的生存率。对于子宫内膜Ⅰ期透明细胞癌,单纯手术或联合放疗是首选治疗方法。女性生殖道透明细胞癌起源于苗勒管而非中肾管的最有力证据是其存在于苗勒管衍生物子宫内膜中。支持这一概念的更具体证据包括:两例透明细胞癌局限于其他方面均为良性的子宫内膜息肉中;另外三例透明细胞癌与典型腺癌紧密混合;21例中均未发现中肾管残余。